Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Dow
Cerilliant
Deloitte
US Department of Justice
UBS
QuintilesIMS
Chubb
Fuji

Generated: November 17, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020977

« Back to Dashboard

NDA 020977 describes ZIAGEN, which is a drug marketed by Viiv Hlthcare and is included in two NDAs. It is available from two suppliers. There are two patents protecting this drug and two Paragraph IV challenges. Additional details are available on the ZIAGEN profile page.

The generic ingredient in ZIAGEN is abacavir sulfate. There are twelve drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the abacavir sulfate profile page.
Summary for 020977
Tradename:ZIAGEN
Applicant:Viiv Hlthcare
Ingredient:abacavir sulfate
Patents:1
Formulation / Manufacturing:see details
Pharmacology for NDA: 020977
Suppliers and Packaging for NDA: 020977
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ZIAGEN abacavir sulfate TABLET;ORAL 020977 NDA ViiV Healthcare Company 49702-221 49702-221-18 1 BOTTLE in 1 CARTON (49702-221-18) > 60 TABLET, FILM COATED in 1 BOTTLE
ZIAGEN abacavir sulfate TABLET;ORAL 020977 NDA ViiV Healthcare Company 49702-221 49702-221-44 6 BLISTER PACK in 1 DOSE PACK (49702-221-44) > 10 TABLET, FILM COATED in 1 BLISTER PACK

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrengthEQ 300MG BASE
Approval Date:Dec 17, 1998TE:ABRLD:Yes
Patent:➤ Try a Free TrialPatent Expiration:Nov 14, 2018Product Flag?Substance Flag?Delist Request?Y

Expired US Patents for NDA 020977

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Viiv Hlthcare ZIAGEN abacavir sulfate TABLET;ORAL 020977-001 Dec 17, 1998 ➤ Try a Free Trial ➤ Try a Free Trial
Viiv Hlthcare ZIAGEN abacavir sulfate TABLET;ORAL 020977-001 Dec 17, 1998 ➤ Try a Free Trial ➤ Try a Free Trial
Viiv Hlthcare ZIAGEN abacavir sulfate TABLET;ORAL 020977-001 Dec 17, 1998 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
QuintilesIMS
Cantor Fitzgerald
Farmers Insurance
Boehringer Ingelheim
US Department of Justice
Citi
Johnson and Johnson
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.